Results from a retrospective study compared and explored biomarkers associated with outcomes in myelodysplastic syndrome (MDS) with plasma cell neoplasms. MDS is a group of heterogeneous clonal ...
Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative ...
The two perspectives — “It’s all about the clone!” and “The niche is the key!” — were presented by Klaus Metzeler, University Hospital Leipzig, Leipzig, Germany, and Tata Nageswara Rao, Cantonal ...
The IPSS-del(5q) Scoring System shows that factors including male sex, cytopenias, and complex genetic background worsen the prognosis of MDS-del(5q). The International Prognostic Scoring System (IPSS ...
Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...
Smoking may contribute to genetic mutations and disease progression in myelodysplastic syndromes, a recent study found. Results from a recent study showed that, in patients with myelodysplastic ...
Newswise — MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL DEC. 9, 2024, AT 9 PM EST) – Smokers with myelodysplastic syndromes (MDS) or a precursor condition had elevated levels of genetic mutations linked ...
Think of the bone marrow as the body’s factory for blood and immune cells. In myelodysplastic syndromes (MDS), that factory breaks down—producing too few cells, and the ones that do roll off the line ...
Tobacco smoking is linked to specific genetic mutations in MDS, affecting chromatin modification and RNA splicing pathways. A dose-response relationship exists, with higher smoking intensity ...
Please provide your email address to receive an email when new articles are posted on . Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers.